Sign In
Buy PRTA
$8.92
-0.270 (-2.94%)
At Close: Jun 03, 2026
VRTX vs. PRTA: Which Stock Should Value Investors Buy Now?
01:12pm, Friday, 16'th Jul 2021
VRTX vs. PRTA: Which Stock Is the Better Value Option?
Where Prothena Corp Stands With Analysts
01:43pm, Tuesday, 13'th Jul 2021
Prothena Corp (NASDAQ:PRTA) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 2 0 2 0 Somewhat Bullish 1 0 1 0 Indifferent
Novo Nordisk To Buy Prothena's ATTR Amyloidosis Program For Up To $1.2B
08:30am, Monday, 12'th Jul 2021
Novo Nordisk A/S (NYSE: NVO) will acquire Prothena Corporation plc's (NASDAQ: PRTA) and clinical stage antibody PRX004 and broader ATTR amyloidosis program. PRX004 is a Phase 2 ready immunothera
Prothena sells amyloidosis portfolio to Novo Nordisk for up to $1.2 billion
07:24am, Monday, 12'th Jul 2021
Shares of Prothena Corp. Plc were up 1.3% in premarket trading on Monday after the company announced a deal to sell its ATTR amyloidosis portfolio to Novo Nordisk in a $100 million deal that is worth
Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion
07:08am, Monday, 12'th Jul 2021
Danish drugmaker Novo Nordisk will acquire U.S. drug developer Prothena Corp's experimental heart therapy, PRX004, in a deal that could be worth up to $1.23 billion, the companies said on Monday.
Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena's ATTR Amyloidosis Programme
07:00am, Monday, 12'th Jul 2021
DUBLIN, Ireland and BAGSVÆRD, Denmark, July 12, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA) and Novo Nordisk A/S (Nasdaq Copenhagen: NOVO B) today announced that the companies hav
Strength Seen in Prothena (PRTA): Can Its 7.3% Jump Turn into More Strength?
05:25am, Monday, 12'th Jul 2021
Prothena (PRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Prothena: Well-Positioned In Parkinson's And Alzheimer's
10:25am, Tuesday, 29'th Jun 2021
Prothena has developed broad expertise in removing plaques across different pathologies.
Will Prothena Stock Rebound After A 13% Drop Last Week?
09:30am, Thursday, 24'th Jun 2021
The stock price of Prothena Corporation (NASDAQ: PRTA), a biotechnology company focused on treatment of diseases that involve protein misfolding or cell adhesion, has seen a a large 13% drop over the
Here's Why Prothena (PRTA) Stock Is Up So Far This Month
04:32pm, Monday, 21'st Jun 2021
Prothena (PRTA) surges on the prospects of its Alzheimer's disease drug candidates, following Biogen???s AD drug approval.
Why Biogen, Lilly, and Prothena Stocks Soared This Week
04:19pm, Thursday, 10'th Jun 2021
The FDA's approval of Biogen's Aduhelm in treating Alzheimer's disease boosted all three stocks.
Prothena to Participate in JMP Securities Life Sciences Conference on June 16
02:18pm, Thursday, 10'th Jun 2021
DUBLIN, Ireland, June 10, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of investigational therapeutics built on protein dysreg
Prothena (PRTA) Up 78.2% Since Last Earnings Report: Can It Continue?
12:02pm, Thursday, 10'th Jun 2021
Prothena (PRTA) reported earnings 30 days ago. What's next for the stock?
Prothena (PRTA) Moves 5.9% Higher: Will This Strength Last?
06:01am, Wednesday, 09'th Jun 2021
Prothena (PRTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength d
Healthcare And Biotech Stocks Face Important Decisions, Remain A Promising Investment
10:27am, Wednesday, 02'nd Jun 2021
Healthcare faces an important decision as the Supreme Court decides on the Affordable Care Act. Biotechs face an important FDA decision on approval of an Alzheimer's treatment.
